REATA PHARMACEUTICALS INC short interest in 2023
In 2023, REATA PHARMACEUTICALS INC's disclosed short interest ran from 22.20% of shares outstanding on 13 Jan 2023 to 6.28% on 15 Sep 2023, a change of -15.92 percentage points. The year's high was 24.05% on 15 Feb 2023 and its low 6.28% on 15 Sep 2023, averaging 13.99% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.96 days on 13 Jan 2023. Full history: REATA PHARMACEUTICALS INC.
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023
2023 in figures
- Start of year
- 22.20% (13 Jan 2023)
- End of year
- 6.28% (15 Sep 2023)
- Change
- -15.92 pp
- High
- 24.05% (15 Feb 2023)
- Low
- 6.28% (15 Sep 2023)
- Average
- 13.99%
- Highest days to cover
- 14.96 (13 Jan 2023)
- SEC filings marked
- 4
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 22.20% | 14.96 | |
| 31 Jan 2023 | 22.94% | 11.80 | |
| 15 Feb 2023 | 24.05% | 10.85 | |
| 28 Feb 2023 | 22.75% | 2.19 | 10-K filed |
| 15 Mar 2023 | 13.69% | 1.76 | |
| 31 Mar 2023 | 13.73% | 6.99 | |
| 14 Apr 2023 | 14.09% | 9.39 | |
| 28 Apr 2023 | 13.05% | 10.90 | |
| 15 May 2023 | 13.65% | 4.93 | 10-Q filed, results (8-K) |
| 31 May 2023 | 11.59% | 4.20 | |
| 15 Jun 2023 | 10.43% | 5.69 | |
| 30 Jun 2023 | 10.67% | 4.53 | |
| 14 Jul 2023 | 10.20% | 8.59 | |
| 31 Jul 2023 | 10.75% | 2.16 | |
| 15 Aug 2023 | 11.01% | 4.24 | 10-Q filed |
| 31 Aug 2023 | 6.80% | 4.00 | |
| 15 Sep 2023 | 6.28% | 3.09 |
See also: REATA PHARMACEUTICALS INC's full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.